Aug 14, 2020
Bushu Pharmaceuticals Announces Major Expansion Program
Aug 12, 2020
NDA Partners in Conjunction with RJR Consulting and Intrinsik Supports Successful CTA Approval by Health Canada for First-in-Human Clinical Study
Aug 12, 2020
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Aug 12, 2020
Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 11, 2020
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020
Aug 11, 2020
CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET
Jun 22, 2020
Evergreen Theragnostics Completes $19 Million Series A Capital Raise
Jun 22, 2020
Citius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor Forum
Jun 20, 2020
Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.
Jun 20, 2020
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 17, 2020
Salicylic Acid Market to Garner $490.8 Million, Globally, By 2027 at 8.0% CAGR, Says Allied Market Research
Jun 16, 2020
CANbridge Pharmaceuticals Appoints Senior Vice President/Global Head of Business Development
Jun 15, 2020
Respiratory Diseases Drugs Market Analysis - Global Outlook and Anlaysis of COVID-19 Implications for the Industry
Jun 14, 2020
Viva BioInnovator (VBI) Successfully Held 1st Demo Day
Jun 11, 2020
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum
Jun 10, 2020
MYR Pharmaceuticals has incorporated its first European subsidiary in France
Jun 10, 2020
Vivera Pharmaceuticals Files First of Two US Made COVID-19 Antibody Tests
Jun 10, 2020
Menarini Group Completes a Solid Year of Operating Performance
Jun 09, 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Jun 09, 2020
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast to Reach USD 224.9 Billion by 2025, Registering a CAGR of 7%, During the Period of 2020-2025